0000899243-22-014878.txt : 20220415
0000899243-22-014878.hdr.sgml : 20220415
20220415161521
ACCESSION NUMBER: 0000899243-22-014878
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210312
FILED AS OF DATE: 20220415
DATE AS OF CHANGE: 20220415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ridloff Elena
CENTRAL INDEX KEY: 0001772518
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39460
FILM NUMBER: 22830186
MAIL ADDRESS:
STREET 1: C/O ACADIA PHARMACEUTICALS INC.
STREET 2: 12830 EL CAMINO REAL, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kymera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001815442
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 812992166
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 857-285-5314
MAIL ADDRESS:
STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-03-12
2021-03-16
0
0001815442
Kymera Therapeutics, Inc.
KYMR
0001772518
Ridloff Elena
C/O KYMERA THERAPEUTICS, INC.
200 ARSENAL YARDS BLVD., SUITE 230
WATERTOWN
MA
02472
1
0
0
0
Stock Option (Right to Buy)
56.10
2021-03-12
4
A
0
20919
0.00
A
2031-03-11
Common Stock
20919
20919
D
The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years commencing on March 12, 2021.
This Amended Form 4 restates the original Form 4 in its entirety.
/s/ Bruce Jacobs, as Attorney-in-Fact
2022-04-15